Pharmacological and emerging therapies in the treatment of chronic angina

Lancet
Steen E Husted, E Magnus Ohman

Abstract

Chronic angina is a common manifestation of ischaemic heart disease. Medical treatments are the mainstay approach to reduce the occurrence of angina and improve patients' quality of life. This Series paper focuses on commonly used standard treatments (eg, nitrates, β blockers, and calcium-channel blockers), emerging anti-angina treatments (which are not available in all parts of the world), and experimental treatments. Although many emerging treatments are available, evidence is scarce about their ability to reduce angina and ischaemia.

References

Mar 23, 1990·JAMA : the Journal of the American Medical Association·B M PsatyT S Inui
Aug 18, 1988·The New England Journal of Medicine·UNKNOWN Multicenter Diltiazem Postinfarction Trial Research Group
Feb 1, 1988·The American Journal of Cardiology·H SuryapranataP G Hugenholtz
Jun 4, 1987·The New England Journal of Medicine·J O ParkerG Moe
Jun 19, 1971·Lancet·L J LyonS Henry
Dec 4, 1971·British Medical Journal·C J Burns-CoxJ R Rees
May 1, 1983·International Journal of Cardiology·H D White, J B Lowe
May 1, 1981·Journal of Cardiovascular Pharmacology·J H HorganK K Teo
Jun 1, 1981·American Heart Journal·C J PepineC R Conti
Feb 1, 1993·Cardiovascular Drugs and Therapy·S Di SommaM de Divitiis
Jan 1, 1995·European Journal of Clinical Pharmacology·K BomanS O Olsson
Feb 19, 1998·The New England Journal of Medicine·J D Parker, J O Parker
Aug 26, 1998·The New England Journal of Medicine·S S GottliebR A Vogel
Jun 1, 1999·JAMA : the Journal of the American Medical Association·P A HeidenreichM A Hlatky
Nov 5, 1999·The New England Journal of Medicine·D R Abernethy, J B Schwartz
Mar 20, 2002·Circulation·Cindy L GrinesRobert L Engler
May 4, 2002·The American Journal of Cardiology·Morten BøttcherTorsten Toftegaard Nielsen
Nov 1, 2002·Journal of Cardiovascular Pharmacology·Hiroaki ShimokawaKazuzo Kato
Jan 25, 2003·Clinical Nuclear Medicine·Vinicius LudwigDominique Delbeke
Mar 19, 2003·Circulation·Timothy D HenryUNKNOWN VIVA Investigators
Oct 18, 2003·Journal of the American College of Cardiology·Cindy L GrinesUNKNOWN Angiogene GENe Therapy (AGENT-2) Study Group
May 18, 2004·Journal of the American College of Cardiology·Steven J KernisCindy L Grines
Sep 8, 2004·Lancet·Philip A Poole-WilsonUNKNOWN Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators
Jan 29, 2005·International Journal of Cardiology·Roger MessinJoseph Géczy
Oct 11, 2005·European Heart Journal·Jean-Claude TardifUNKNOWN INITIATIVE Investigators
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Suzanne V ArnoldUNKNOWN MERLIN-TIMI 36 Investigators
Apr 22, 2010·Cardiovascular Therapeutics·Steve Attanasio, Gary Schaer
May 12, 2011·BMJ : British Medical Journal·Philip M ShortBrian J Lipworth

❮ Previous
Next ❯

Citations

Mar 26, 2016·Pharmacology & Therapeutics·Andreas A GiannopoulosYiannis S Chatzizisis
Mar 24, 2016·The New England Journal of Medicine·E Magnus Ohman
Jul 29, 2016·The New England Journal of Medicine·E Magnus Ohman
Sep 1, 2016·Cardiovascular Drugs and Therapy·Isaac PascualPablo Avanzas
Sep 24, 2016·Expert Opinion on Drug Safety·Talla A RousanUdho Thadani
Sep 15, 2016·Clinical and Experimental Pharmacology & Physiology·Alice E Kane, Susan E Howlett
Dec 10, 2016·Expert Review of Cardiovascular Therapy·Francesco GianniniAzeem Latib
Jan 26, 2017·Drugs·Talla A RousanUdho Thadani
Mar 31, 2017·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Csaba András Dézsi, Veronika Szentes
Jun 7, 2018·Cardiology·Cristina BallaRoberto Ferrari
Sep 8, 2017·Nature Reviews. Cardiology·Roberto FerrariJosé L Lopez-Sendon
Feb 22, 2017·Advances in Therapy·Maria Glezer, UNKNOWN CHOICE-2 study investigators
Sep 11, 2019·European Heart Journal·Juhani KnuutiUNKNOWN ESC Scientific Document Group
Feb 6, 2021·Circulation. Cardiovascular Interventions·Thomas J PovsicE Magnus Ohman
Jul 29, 2016·The New England Journal of Medicine·Mayer Bassan
Jun 4, 2021·Current Cardiology Reports·Francesco MoroniLorenzo Azzalini
Jul 9, 2021·Nature Reviews. Cardiology·Edoardo BerteroChristoph Maack
Jul 17, 2021·Cardiovascular Research·Alexandra PetrainaHarald H H W Schmidt
Aug 23, 2021·European Journal of Internal Medicine·Manolis AjRosano G
Nov 19, 2021·Expert Opinion on Pharmacotherapy·Jayakumar SreenivasanWilbert S Aronow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.